Thanks for reposting my thoughts on why ResAppDx is critical.
On the issue of what this regulatory update may be about, from what I heard, the US is currently in real trouble with COVID-19. It's much much worse then what Donald Trump says, and worse than what the media is reported. Heard it from a direct source, an elderly who lives in NY at the moment.
If Australia is desperate, you can bet Europe and US are a million times more desperate than us.
I really don't think FDA has anytime to ask additional question. Nor would it be a politically saavy time to announce a turn down on the telehealth device that may help deal with a pandemic.
So my take is, it has to do with fast track on either FDA, or CFDA (or both??)
RAP Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
